US Intravenous Immunoglobulin Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. US Intravenous Immunoglobulin Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. US Intravenous Immunoglobulin Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. US Intravenous Immunoglobulin Market Country Analysis

6.2 US Intravenous Immunoglobulin Market Revenue 2020-2028 (US$ Million)

6.3 US Intravenous Immunoglobulin Market Forecast Analysis

7. US Intravenous Immunoglobulin Market Analysis – by Type

7.1 IgG

7.1.1 Overview
7.1.2 IgG: US Intravenous Immunoglobulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 IgM

7.2.1 Overview
7.2.2 IgM: US Intravenous Immunoglobulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.3 IgA

7.3.1 Overview
7.3.2 IgA: US Intravenous Immunoglobulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. US Intravenous Immunoglobulin Market Analysis – by Application

8.1 Hypogammaglobulinemia

8.1.1 Overview
8.1.2 Hypogammaglobulinemia: US Intravenous Immunoglobulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Chronic Inflammatory Demyelinating Polyneuropathy

8.2.1 Overview
8.2.2 Chronic Inflammatory Demyelinating Polyneuropathy: US Intravenous Immunoglobulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.3 Immunodeficiency Diseases

8.3.1 Overview
8.3.2 Immunodeficiency Diseases: US Intravenous Immunoglobulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.4 Myasthenia Gravis

8.4.1 Overview
8.4.2 Myasthenia Gravis: US Intravenous Immunoglobulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.5 Multifocal Motor Neuropathy

8.5.1 Overview
8.5.2 Multifocal Motor Neuropathy: US Intravenous Immunoglobulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.6 Idiopathic Thrombocytopenic Purpura

8.6.1 Overview
8.6.2 Idiopathic Thrombocytopenic Purpura: US Intravenous Immunoglobulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.7 Inflammatory Myopathies

8.7.1 Overview
8.7.2 Inflammatory Myopathies: US Intravenous Immunoglobulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.8 Specific Antibody Deficiency

8.8.1 Overview
8.8.2 Specific Antibody Deficiency: US Intravenous Immunoglobulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.9 Guillain-Barre Syndrome

8.9.1 Overview
8.9.2 Guillain-Barre Syndrome: US Intravenous Immunoglobulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. US Intravenous Immunoglobulin Market Analysis – by Distribution Channel

9.1 Hospital Pharmacy

9.1.1 Overview
9.1.2 Hospital Pharmacy: US Intravenous Immunoglobulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Retail Pharmacy

9.2.1 Overview
9.2.2 Retail Pharmacy: US Intravenous Immunoglobulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. US Intravenous Immunoglobulin Market Analysis – by End User

10.1 Hospitals

10.1.1 Overview
10.1.2 Hospitals: US Intravenous Immunoglobulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.2 Specialty Clinics

10.2.1 Overview
10.2.2 Specialty Clinics: US Intravenous Immunoglobulin Market – Revenue and Forecast, 2020-2028 (US$ Million)

11. US Intravenous Immunoglobulin Market – United States Analysis

11.1 United States

11.1.1 United States: US Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1 United States: US Intravenous Immunoglobulin Market Breakdown, by Type
11.1.1.2 United States: US Intravenous Immunoglobulin Market Breakdown, by Application
11.1.1.3 United States: US Intravenous Immunoglobulin Market Breakdown, by Distribution Channel
11.1.1.4 United States: US Intravenous Immunoglobulin Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Takeda Pharmaceuticals Co Ltd

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Grifols SA

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Pfizer Inc

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 ADMA Biologics

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Bio Products Laboratory Ltd

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Octapharma AG

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Kedrion SpA

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 CSL Ltd

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 LFB Group

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Prothya Biosolutions BV

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

US Intravenous Immunoglobulin Market